PDF(825 KB)
Juvenile Parkinson’s disease caused by PRKN gene compound heterozygous mutation: A case report and literature review
Qian LI,Chunyang KANG,Xiaoyang LIU,Libo WANG,Jiajun CHEN,Jia LI
PDF(825 KB)
PDF(825 KB)
Juvenile Parkinson’s disease caused by PRKN gene compound heterozygous mutation: A case report and literature review
)Objective To conduct the genetic analysis of a family with one patient suffering from juvenile Parkinson’s disease （JP） and discuss the clinical manifestations， genetic mutation characteristics， and treatment plans prompted by PRKN gene compound heterozygous mutations，and to enhance the clinicians’ awareness of this disease. Methods The clinical data of one patient with JP caused by PRKN gene mutations was analyzed， the clinical manifestations and genetic mutation features of the patient were summarized， and the related literatures were reviewed. Results The patient， a 16-year-old male， was admitted to the hospital due to unstable gait， trembling limbs with rigidity in both lower limbs for three years.The examination results revealed a panic gait， clear consciousness， fluent speech， normal muscle strength in limbs， increased “gear-like” muscle tone in both upper limbs， and “lead-pipe” rigidity in both lower limbs；the sensory functions and tendon reflexes were normal. The head， neck， and thoracic magnetic resonance imaging （MRI） results showed no abnormalities. 18F-fluorodeoxyglucose （18F-FDG） positron emission tomography/computed tomography （PET/CT）results showed that the head size and shape were normal， the glucose metabolism in the left cerebellum and middle temporal gyrus was slightly decreased， and the glucose metabolism in bilateral thalami， right frontal lobe， parietotemporal lobe， and left medial frontal lobe was increased. The dopamine transporter （DAT） PET/CT results showed that there was no radioactive distribution in the brain cortex and the DAT distribution in the posterior part of both striata was decreased. The whole-exome sequencing results showed the patient had two PRKN gene mutations，such as codons c.8T>A and c.850G>C compound heterozygous mutations，and each mutation was from one parent；the patient’s father carried the c.8T>A mutation， the patient’s mother carried the c.850G>C mutation， and the patient’s sister had the same genetic mutation site as the patient’s father. Conclusion PRKN gene compound heterozygous mutations may be the basis of the disease in this family. Identification of the mutation c.8T>A expands the mutation spectrum of the PRKN gene， and provides the valuable information for the research on the pathogenic genetic mutations of the JP patients.
Juvenile / Parkinson’s disease / PRKN gene / Gene mutation
R748
| 1 | 肖 琪， 樊慧杰， 李艳荣， 等. 帕金森病发病机制研究进展［J］. 解放军医学杂志，2023，48（8）： 983-992. |
| 2 | 庞文渊， 翟利杰， 刘依琳， 等. 全球帕金森病综合治疗指南的分析［J］. 中国临床药理学杂志， 2022， 38（21）： 2638-2643. |
| 3 | KUKKLE P L， GOYAL V， GEETHA T S， et al. Clinical study of 668 Indian subjects with juvenile， young， and early onset Parkinson’s disease［J］. Can J Neurol Sci， 2022， 49（1）： 93-101. |
| 4 | CHERIAN A， DIVYA K P. Genetics of Parkinson’s disease［J］. Acta Neurol Belg， 2020： 1-9. |
| 5 | ZHU W， HUANG X P， YOON E， et al. Heterozygous PRKN mutations are common but do not increase the risk of Parkinson’s disease［J］. Brain， 2022， 145（6）： 2077-2091. |
| 6 | ISHIKAWA A， TSUJI S.Clinical analysis of 17 patients in 12 Japanese families with autosomal-recessive type juvenile Parkinsonism［J］.Neurology， 1996，47（1）：160-166. |
| 7 | MATSUMINE H， SAITO M， SHIMODA-MATSUBAYASHI S， et al. Localization of a gene for an autosomal recessive form of juvenile Parkinsonism to chromosome 6q25.2-27［J］. Am J Hum Genet， 1997， 60（3）： 588-596. |
| 8 | ZHANG Y， TARTAGLIA M C， ZHAN W， et al. Editorial： neuroimaging in Parkinson’s disease and Parkinsonism［J］. Front Neurol， 2023， 14： 1153682. |
| 9 | KITADA T， ASAKAWA S， HATTORI N， et al. Mutations in the parkin gene cause autosomal recessive juvenile Parkinsonism［J］. Nature， 1998， 392（6676）： 605-608. |
| 10 | SHIMURA H， HATTORI N， et al. Familial Parkinson disease gene product， parkin， is a ubiquitin-protein ligase［J］. Nat Genet， 2000， 25（3）： 302-305. |
| 11 | SHIMURA H， SCHLOSSMACHER M G， HATTORI N， et al. Ubiquitination of a new form of alpha-synuclein by parkin from human brain： implications for Parkinson’s disease［J］. Science， 2001， 293（5528）： 263-269. |
| 12 | 毛 薇， 许二赫， 张 慧， 等. 早发帕金森病临床特征、多巴转运体PET显像及基因突变分析［J］. 中国神经免疫学和神经病学杂志， 2017， 24（1）： 2-6. |
| 13 | OPLADEN T， LóPEZ-LASO E， CORTèS-SALADELAFONT E， et al. Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin （BH4） deficiencies［J］.Orphanet J Rare Dis，2020，15（1）： 126. |
| 14 | 中华医学会神经病学分会帕金森病及运动障碍学组， 中国医师协会神经内科医师分会帕金森病及运动障碍学组. 中国中晚期帕金森病运动症状治疗的循证医学指南［J］. 中国神经免疫学和神经病学杂志， 2021， 28（5）： 347-360. |
| 15 | 中华医学会神经病学分会帕金森病及运动障碍学组， 中国医师协会神经内科医师分会帕金森病及运动障碍学组. 早发型帕金森病的诊断与治疗中国专家共识［J］. 中华神经医学杂志， 2021， 20（2）： 109-116. |
| 16 | CHEN H， HUANG X J， YUAN L M， et al. A homozygous parkin p.G284R mutation in a Chinese family with autosomal recessive juvenile Parkinsonism［J］. Neurosci Lett， 2016， 624： 100-104. |
| 17 | LI T B， KOU D Q， CUI Y H， et al. Whole exome sequencing identified a new compound heterozygous PRKN mutation in a Chinese family with early-onset Parkinson’s disease［J］. Biosci Rep，2020，40（5）： BSR20200534. |
| 18 | WU R M， BOUNDS R， LINCOLN S， et al. Parkin mutations and early-onset Parkinsonism in a Taiwanese cohort［J］. Arch Neurol， 2005， 62（1）： 82-87. |
| 19 | 段春霞， 黄 卫， 王子裕. 存在LRRK2和Parkin基因罕见位点突变的早发性帕金森病一例［J］. 中国现代神经疾病杂志， 2019， 19（7）： 531-533. |
| 20 | LIM S Y， TAN A H， AHMAD-ANNUAR A， et al. Parkinson’s disease in the western Pacific region［J］. Lancet Neurol， 2019， 18（9）： 865-879. |
| 21 | FOO J N， CHEW E G Y， CHUNG S J， et al. Identification of risk loci for parkinson disease in asians and comparison of risk between asians and Europeans： a genome-wide association study［J］. JAMA Neurol， 2020， 77（6）： 746-754. |
/
| 〈 |
|
〉 |
AI Summary
